For decades the Hitachi name in life sciences and health care has been associated with innovation and medical breakthroughs. Through a diverse group of companies, Hitachi provides a wide range of solutions to these critical markets. It is a Hitachi company that has pioneered the way in breakthrough technologies such as proton beam therapy, DNA sequencers and applied medical biotechnology including intelligent operating rooms. 
E-Health Media Ltd has today announced the launch of EHealthEurope.net, an independent news and business information portal covering the development of the healthcare information technology sector across Europe.
The target audiences for EHealthEurope.net are health professionals, health IT executives, policy makers and influencers, together with their industry partners. The portal will provide them with the news and information they need to stay informed and track developments across this rapidly evolving European marketplace.
100 years ago in October 1907, company founder, Johann Heinrich Dräger, was awarded a patent for the Pulmotor, the first mobile short-term respirator. This marked the birth of ventilation technology development at Dräger. Simple, reliable, and extremely effective, the apparatus - transported in a wooden casket - quickly became a standard piece of equipment used by rescue services throughout Germany. 
Manhattan Research, a healthcare marketing information and services firm, revealed emerging trends of European physicians in Germany, Spain, Italy, France and the United Kingdom. The country-specific insight and data are based on the comprehensive telephone-based research study Taking the Pulse® Europe v5.0, conducted among more than 1,000 European practicing physicians. In today's world of fragmented media and channel mix, it is increasingly difficult to isolate the information sources used by consumers to research health information and inform healthcare decision making. This is especially the case across Europe, where consumers are accessing an expanding range of resources which vary greatly by country and by region. 
Worldwide, five percent of all people over the age of 65 suffer from atrial fibrillation. While cardiac arrhythmia can be treated with medication, patients have to take it for the rest of their lives. Ablation therapy offers an alternative: myocardial cells in the left atrium are obliterated to interrupt the problematic pathway. However, every patient is different. For this reason, electro physiologists have to be able to discern the size and shape of the left ventricle in precise detail during the intervention.